Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

C. Japhet Livia Jardika Jeff Jarvis Mohamed Husnee Jazeel Alain Jeannet Richard A. Jefferson Kevin J. Jenkins Philip J. Jennings Jeong Kim Jean-Luc Jezouin Jiang Jianqing Joseph Jimenez Emmanuel Jimenez Naveen Jindal Jeffrey Joerres Josef Joffe Bjorn Johansson H. Fisk Johnson Simon Johnson Ray

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

ngdom Philip J. Jennings General Secretary UNI Global Union Switzerland Jeong Kim President, Bell Labs Alcatel-Lucent Bell USA Laboratories Jean-Luc Jezouin Senior Vice-President and General Kudelski Group Switzerland Manager, New Markets Region Jiang Jianqing Chairman of the Board Industrial and C

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

ngdom Philip J. Jennings General Secretary UNI Global Union Switzerland Jeong Kim President, Bell Labs Alcatel-Lucent Bell USA Laboratories Jean-Luc Jezouin Senior Vice-President and General Kudelski Group Switzerland Manager, New Markets Region Jiang Jianqing Chairman of the Board Industrial and C

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco

a Garth C. Japhet Livia Jaréka Jeff Jarvis Mohamed Husnee Jazeel Alain Jeannet Richard A. Jefferson Kevin J. Jenkins Philip J. Jennings Jeong Kim Jean-Luc Jezouin Jiang Jianging Emmanuel Jimenez Joseph Jimenez Naveen Jindal Secretary-General, SEGIB Secretaria General Iberoamericana, Spain Associate Editor and